News

Beijing Qihengxing Biotechnology Co., Ltd. was established in 2018. It is a national high-tech enterprise with many invention patents. Relying on core technology platforms such as enzyme engineering platform, PCR/qPCR system platform, nucleic acid extraction platform, NGS platform with independent intellectual property rights, the company has developed many high-quality products in multiple application directions such as molecular biology, NGS application, and synthetic biology, and has built a

This article provides a comprehensive introduction to PCR technology, including its basic principles and steps. PCR specificity relies on oligonucleotide primers that are complementary to both ends of the target sequence, and DNA amplification is achieved through three steps: denaturation, annealing, and extension. The article elaborates on the principles, steps, primer design techniques, and result analysis methods of PCR experiments, as well as the differences, experimental techniques, and com

In the paper published on July 4, "Suppression of insulin feedback enhances the efficacy of PI3K inhibitors," Dr. Lewis C. Cantley's team explored why anticancer drugs targeting PI3K are not effective. PI3K mutations are associated with a variety of cancers, making it a popular target for drug development, but clinical trial results have been disappointing, and some patients have had to stop taking the drug due to hyperglycemia. Studies have found that elevated insulin levels reactivate PI3K, we

HD-Zip (homeodomain-leucine zipper) is a family of transcription factors unique to higher plants, which plays a vital role in plant growth and development. It is widely involved in plant growth, morphogenesis, biotic and abiotic stresses, and other life processes. Cannabis is considered to be an important medicinal plant because it contains many active medicinal ingredients, such as terpenes, flavonoids, phenolic terpenes, and alkaloids. However, the HD-Zip transcription factor of cannabis has n

Qihengxing Bio has launched a qPCR mix for samples with high GC content, which is suitable for experimental research related to molecular biology, cell biology, synthetic biology, enzyme engineering, etc.

Beijing Qihengxing Biotechnology Co., Ltd. was established in 2018. It is a national high-tech enterprise with many invention patents. Relying on core technology platforms such as enzyme engineering platform, PCR/qPCR system platform, nucleic acid extraction platform, NGS platform with independent intellectual property rights, the company has developed many high-quality products in multiple application directions such as molecular biology, NGS application, and synthetic biology, and has built a